Assessment and Management of Alcohol Withdrawal Seizure

Assessment Components

The American Association for the Study of Liver Diseases recommends documenting alcohol consumption pattern and duration to determine severity of alcohol use disorder (AUD) using DSM-V criteria 1
The assessment should include evaluating for comorbid medical conditions that may affect treatment approach, such as liver disease or other alcohol-related organ damage 1, 2
A neurological examination should be performed to rule out focal deficits that would suggest alternative etiology, and to assess for signs of head trauma that may have occurred during seizure 3, 4
The patient's vital signs should be monitored, with particular attention to tachycardia, hypertension, and hyperthermia as indicators of autonomic hyperactivity 2

The American College of Clinical Pharmacology recommends administering benzodiazepines as first-line therapy for seizure prevention and withdrawal symptom control, with dosing based on Clinical Institute Withdrawal Assessment for Alcohol (CIWA) scores 2, 5
Thiamine supplementation should be provided to prevent Wernicke encephalopathy, with a recommended dose of 100-300 mg/day 2, 5, 6
The patient should be monitored regularly for progression to more severe withdrawal symptoms, including hallucinations or delirium tremens 2

Inpatient admission should be considered for patients with a history of severe withdrawal symptoms or delirium tremens, multiple seizures or status epilepticus, or significant medical or psychiatric comorbidities 2, 5
The American Society of Addiction Medicine recommends arranging psychiatric consultation for evaluation, treatment, and long-term planning for alcohol abstinence 2
Education should be provided about the risks of continued alcohol use and the benefits of abstinence, and the patient should be connected with addiction treatment resources 1